ETC-1002
ETC-1002-004
Phase 1 small_molecule completed
Quick answer
ETC-1002 for Safety Evaluation of Escalating Doses is a Phase 1 program (small_molecule) at Esperion Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Esperion Therapeutics
- Indication
- Safety Evaluation of Escalating Doses
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed